Sonnet Biotherapeutics HoldiSONN
13F holders, Q2 2025 (June 30)9holders +1
2new positions
1sold out
$1.24avg. 13F price*
At the end of Q2 2025, 9 institutions reported holding Sonnet Biotherapeutics Holdi (SONN) in their 13F filings, up 1 from Q1 2025. 2 opened new positions and 1 sold out. The largest holders were MMCAP International Inc. SPC ($166K), Geode Capital Management, LLC ($31K) and XTX Topco Ltd ($17K).
- Company
- Sonnet Biotherapeutics Holdi
- CUSIP
- 83548R402
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $17K |
| Exits | 1 | $23 |
All 13F filers, Q1 2025 → Q2 2025: 20,282 shares bought and 1,139 shares sold, net +19,143 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| MMCAP International Inc. SPC | 0.02% | No change | 133,590 | $166K |
| Geode Capital Management, LLC | 0.00% | Add +0.3% | 24,892 | $31K |
| XTX Topco Ltd | 0.00% | New | 13,668 | $17K |
| UBS Group AG | 0.00% | Add +4622.7% | 6,659 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -43.4% | 1,465 | $2K |
| BlackRock, Inc. | 0.00% | No change | 65 | $81 |
| Carolina Wealth Advisors, LLC | 0.00% | No change | 32 | $40 |
| Bank of America Corp. | 0.00% | Add +11.5% | 29 | $36 |
| Raymond James Financial Inc. | 0.00% | New | 6 | $7 |
"% of holder's portfolio" is SONN's weight in each manager's 13F, not the share of Sonnet Biotherapeutics Holdi the manager owns.